GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nyrada Inc (ASX:NYR) » Definitions » Other Stockholders Equity

Nyrada (ASX:NYR) Other Stockholders Equity : A$-0.00 Mil (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Nyrada Other Stockholders Equity?

Nyrada's Other Stockholders Equity for the quarter that ended in Dec. 2023 was A$-0.00 Mil.

Nyrada's quarterly Other Stockholders Equity declined from Dec. 2022 (A$0.00 Mil) to Jun. 2023 (A$-0.00 Mil) but then stayed the same from Jun. 2023 (A$-0.00 Mil) to Dec. 2023 (A$-0.00 Mil).

Nyrada's annual Other Stockholders Equity declined from Jun. 2021 (A$0.00 Mil) to Jun. 2022 (A$0.00 Mil) and declined from Jun. 2022 (A$0.00 Mil) to Jun. 2023 (A$-0.00 Mil).


Nyrada Other Stockholders Equity Historical Data

The historical data trend for Nyrada's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nyrada Other Stockholders Equity Chart

Nyrada Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23
Other Stockholders Equity
- - - - -

Nyrada Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Stockholders Equity Get a 7-Day Free Trial - - - - -

Nyrada Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


Nyrada Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Nyrada's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Nyrada (ASX:NYR) Business Description

Industry
Traded in Other Exchanges
N/A
Address
828 Pacific Highway, Suite 2, Level 3, Gordon, NSW, AUS, 2072
Nyrada Inc is a preclinical-stage, drug discovery, and development company, specializing in novel small-molecule drugs to treat cardiovascular and neurological diseases. The company's two programs center on cholesterol-lowering and brain injury, each targeting market sectors of notable size and unmet clinical needs. The programs are focused on developing an oral, small molecule cholesterol-lowering drug, and a drug to treat secondary brain damage following a stroke or traumatic brain injury.

Nyrada (ASX:NYR) Headlines

No Headlines